Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIUNITE-08: Tolecizumab + Chemoimmunotherapy in Locally Advanced Colon Adenocarcinoma
NCT07468630Phase 2Recruiting
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of HS628 in colon adenocarcinoma. Started Apr 2026; status: recruiting.
02
Drugs
HS628
03
Conditions
colon adenocarcinoma
Beyond the preview
Go deeper on NCT07468630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07468630.